Sprache NL EN DE ES FR UK IT

Neubauanalyse

Kartellanalyse

Saubere Grundlage für MEP-, Dokument- und thematische Netzwerkanalyse. Keine harten politischen Labels, sondern überprüfbare Evidenz.

You are here

Transparency and ethics in the EU: text message exchange between Ursula von der Leyen and Pfizer CEO Albert Bourla

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

Transparency and ethics in the EU: text message exchange between Ursula von der Leyen and Pfizer CEO Albert Bourla

Schriftelijke vraag | - | source: parliamentary_questions

Open bronpagina Leesbare metadata Wikipedia zoeken

Pfizer en covid
1Actors
1Signals
9EP term

Actors

Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

Transparency and ethics in the EU: text message exchange between Ursula von der Leyen and Pfizer CEO Albert Bourla

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer parliamentary_questions
Canonical identifier E-9-2022-000382
Official source URL https://data.europarl.europa.eu/eli/dl/doc/E-9-2022-000382
Title and language layer English primary, Dutch fallback
EP term 9

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: -
Keywords: Transparency and ethics in the EU
Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News
Supporting layers Signals

Signals

topic-match / pfizer-covid

Value: 0.8000

Transparency and ethics in the EU: text message exchange between Ursula von der Leyen and Pfizer CEO Albert Bourla Julie Lechanteux

Linked vote events Votes and seat distribution

Linked vote events

No official vote items linked to this dossier yet.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard